Carterra Overview
- Year Founded
-
2005
- Status
-
Private
- Employees
-
81
- Latest Deal Type
-
General Corporate Purpose
- Investors
-
8
Carterra General Information
Description
Operator of a biosensor platform intended to accelerate the discovery of novel therapeutic candidates. The company's monoclonal antibody (mAb) characterization platform combines patented microfluidic technology with real-time high-throughput surface plasmon resonance (HT-SPR), kinetic and epitope analysis, and visualization software, enabling pharmaceutical and biotechnology clients to rapidly and comprehensively screen antibodies and identify potential novel therapeutic candidates.
Contact Information
Website
www.carterra-bio.comCorporate Office
- 825 North 300 West
- Suite C309
- Salt Lake City, UT 84103
- United States
Corporate Office
- 825 North 300 West
- Suite C309
- Salt Lake City, UT 84103
- United States
Carterra Timeline
Carterra Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 20. General Corporate Purpose | 01-Apr-2026 | Completed | Generating Revenue | |||
| 19. Later Stage VC | 23-Apr-2024 | Completed | Generating Revenue | |||
| 18. Debt Refinancing | 13-Apr-2023 | Completed | Generating Revenue | |||
| 17. Later Stage VC | 13-May-2021 | Completed | Generating Revenue | |||
| 16. Secondary Transaction - Private | 01-Apr-2021 | Completed | Generating Revenue | |||
| 15. Later Stage VC (Series G) | 22-Dec-2020 | Completed | Generating Revenue | |||
| 14. Debt - PPP | 27-Apr-2020 | Completed | Generating Revenue | |||
| 13. Later Stage VC (Series F) | 19-Dec-2019 | Completed | Generating Revenue | |||
| 12. Later Stage VC (Series E) | 17-Jan-2018 | $10M | $23.5M | Completed | Generating Revenue | |
| 11. Later Stage VC (Series D) | 17-Aug-2016 | $10.3M | $13.5M | Completed | Generating Revenue |
Carterra Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series G | ||||||||
| Series F | ||||||||
| Series E | ||||||||
| Series D | ||||||||
| Series C | ||||||||
| Series B | 887,170 | $0.001000 | $1.13 | $1.13 | 1x | $1.13 | 3.52% | |
| Series A | 344,923 | $0.001000 | $0.86 | $0.86 | 1x | $0.86 | 1.37% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Carterra Comparisons
Industry
Financing
Details
Carterra Competitors (4)
One of Carterra’s 4 competitors is Nanion Technologies, a Accelerator/Incubator Backed company based in Munich, Germany.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Nanion Technologies | Accelerator/Incubator Backed | Munich, Germany | ||||
| NanoTemper Technologies | Corporation | Munich, Germany | ||||
| SPT Labtech | Private Equity-Backed | Melbourn, United Kingdom | ||||
| Proteros biostructures | Private Equity-Backed | Martinsried, Germany |
Carterra Patents
Carterra Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260016685-A1 | Non-sequential scanning of substances | Pending | 05-Jul-2024 | ||
| WO-2026011027-A2 | Non-sequential scanning of substances | Pending | 05-Jul-2024 | ||
| WO-2026011027-A3 | Non-sequential scanning of substances | Pending | 05-Jul-2024 | ||
| US-20250153170-A1 | Fluid control adapters | Pending | 14-Nov-2023 | ||
| EP-4649303-A1 | Microfluidic flow cell arrays | Pending | 11-Jan-2023 | B01L3/50273 |
Carterra Signals
Carterra Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Revvity | Corporation | Minority | ||
| Ballast Point Partners | Growth/Expansion | Minority | ||
| Shepherd Growth Partners | Venture Capital | Minority | ||
| Telegraph Hill Partners | Venture Capital | Minority | ||
| Frazier VC | Venture Capital | Minority |
Carterra FAQs
-
When was Carterra founded?
Carterra was founded in 2005.
-
Where is Carterra headquartered?
Carterra is headquartered in Salt Lake City, UT.
-
What is the size of Carterra?
Carterra has 81 total employees.
-
What industry is Carterra in?
Carterra’s primary industry is Discovery Tools (Healthcare).
-
Is Carterra a private or public company?
Carterra is a Private company.
-
What is Carterra’s current revenue?
The current revenue for Carterra is .
-
How much funding has Carterra raised over time?
Carterra has raised $42.6M.
-
Who are Carterra’s investors?
Revvity, Ballast Point Partners, Shepherd Growth Partners, Telegraph Hill Partners, and Frazier VC are 5 of 8 investors who have invested in Carterra.
-
Who are Carterra’s competitors?
Nanion Technologies, NanoTemper Technologies, SPT Labtech, and Proteros biostructures are competitors of Carterra.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process